Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

http://www.business-standard.com/article/markets/cipla-shines-in-gloomy-pharma-pack-biggest-beneficiary-of-faster-approvals-117112200268_1.html

Ujjval Jauhari BUSINESS-STANDARD
21 Nov 2017

http://www.business-standard.com/article/companies/cipla-gets-usfda-nod-to-market-generic-version-of-cancer-drug-dacogen-117112000203_1.html

BUSINESS-STANDARD
20 Nov 2017